SCOR has acknowledged an arbitration award confirming the validity of retrocession treaties entered into with Covéa in June 2021. The treaties transfer 30% of the Life & Health portfolio held by SCOR’s Irish entities as at December 31, 2020 to Covéa. The tribunal awarded Covéa compensation of USD 488.3 million, but after provisions the impact on SCOR’s net results at Q2 2026 will be approximately EUR 50 million, with no negative impact on solvency or liquidity. SCOR remains focused on executing the final year of its Forward 2026 plan.
SCOR SEArbitration award requires SCOR to pay EUR 50 million compensation, negatively impacting net results.
Covéa awarded USD 488.3 million compensation, a financial gain from the arbitration.